Skip to main content
. Author manuscript; available in PMC: 2013 May 24.
Published in final edited form as: J Am Coll Cardiol. 2010 Aug 24;56(9):692–699. doi: 10.1016/j.jacc.2010.03.068

Figure 1. Participant Flow Through the Trial.

Figure 1

Completers were participants who completed 12-weeks of study drug and assessment at the end of the 12-week intervention. Non-completers were participants who discontinued study drug prior to 12-weeks. Participants were considered non-compliant if they did not take the study medication for ≥14 consecutive days.